Prostate Cancer - Results from #26920

Incidence of secondary cancer development after high-dose intensity-modulated radiotherapy and image-guided brachytherapy for the treatment of localized prostate cancer - Abstract January 16, 2012

High-grade prostatic adenocarcinoma present in a single biopsy core as associated with increased extraprostatic extension, seminal vesicle invasion, and positive surgical margins at prostatectomy - Abstract January 16, 2012

Prostate cryoablation in patients with multiple-component inflatable penile prostheses - Abstract January 16, 2012

Sun exposure may increase risk of prostate cancer in the high UV environment of New South Wales, Australia: A case-control study - Abstract January 16, 2012

Predictive value of MRI in the localization, staging, volume estimation, assessment of aggressiveness, and guidance of radiotherapy and biopsies in prostate cancer - Abstract January 16, 2012

Novel imaging modalities for lymph node imaging in urologic oncology - Abstract January 16, 2012

Neonatal exposure to Estradiol/Bisphenol A alters promoter methylation and expression of Nsbp1 and Hpcal1 genes and transcriptional programs of Dnmt3a/b and Mbd2/4 in the rat prostate gland throughout life January 13, 2012

Androgen deprivation therapy as primary treatment for prostate cancer - Abstract January 13, 2012

Efficacy and safety of a modular multi-modal exercise program in prostate cancer patients with bone metastases: A randomized controlled trial - Abstract January 13, 2012

Information that affects patients' treatment choices for early stage prostate cancer: A review - Abstract January 13, 2012

Critical assessment of prebiopsy parameters for predicting prostate cancer metastasis and mortality - Abstract January 13, 2012

Assessment of zoledronic acid treatment patterns and clinical outcomes in patients with bone metastases from genitourinary cancers - Abstract January 13, 2012

A critical analysis of the long-term impact of radical prostatectomy on cancer control and function outcomes - Abstract January 13, 2012

Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: Preliminary safety results from the CHHiP randomised controlled trial - Abstract January 13, 2012

Hypofractionated stereotactic body radiotherapy in low-risk prostate adenocarcinoma: Preliminary results of a multi-institutional phase 1 feasibility trial - Abstract January 13, 2012

Clinical and biochemical consequences of CYP17A1 inhibition with abiraterone given with and without exogenous glucocorticoids in castrate men with advanced prostate cancer - Abstract January 13, 2012

Cabazitaxel with radiation and hormone therapy may improve prostate cancer survival January 13, 2012

Open radical retropubic prostatectomy using high anterior release of the levator fascia and constant haptic feedback in bilateral neurovascular bundle preservation plus early postoperative phosphodiesterase type 5 inhibition: A contemporary series - Abstr January 12, 2012

The basis for monitoring strategies in clinical guidelines: A case study of prostate-specific antigen for monitoring in prostate cancer - Abstract January 12, 2012

Multi-field-of-view SPECT is superior to whole-body scanning for assessing metastatic bone disease in patients with prostate cancer - Abstract January 12, 2012

Page 1347 of 1457